Hamps Bio last traded at ₹25.50 (2026-10-13). Over the past month the stock moved +0.0%, three months the stock moved +21.4%, year the stock moved +21.4%. Its closing range over 52 weeks is ₹15.00 – ₹25.99, with the latest close 1.9% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2007, Hamps Bio Ltd is in the business of Pharmaceutical Formulation and Freeze-Drying Ingredient Manufacturing and Distribution[1]
Business Overview:[1] HBL is in the business of ethical marketing and distribution of pharmaceutical formulations across wide range of dosage including tablets, syrups, capsules, injectables, oil, gel and powder used as medicine & nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers.
In the latest quarter (Mar 2026), Hamps Bio reported sales of ₹4.53 crore (+36.0%) and net profit of ₹-0.46 crore (-300.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 4.53 | -0.07 | -1.55 | -0.46 | -0.53 |
| Sep 2025 | 3.99 | 0.18 | 4.51 | -0.20 | -0.23 |
| Mar 2025 | 3.13 | 0.22 | 7.03 | 0.03 | 0.03 |
| Sep 2024 | 3.54 | 0.55 | 15.54 | 0.27 | 0.43 |
| Mar 2024 | 3.33 | 0.55 | 16.52 | 0.23 | 0.59 |
| Mar 2026 | |
|---|---|
| Sales growth | +36.0% |
| Operating profit growth | -112.7% |
| Net profit growth | -300.0% |
| EPS growth | -189.8% |
| OPM % | -1.6% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Hamps Bio reported sales of ₹8.52 crore (+27.7%) and net profit of ₹-0.65 crore (-316.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 8.52 | 0.11 | 1.29 | -0.65 | -0.75 |
| Mar 2025 | 6.67 | 0.77 | 11.54 | 0.30 | 0.69 |
| Mar 2024 | 6.48 | 1.17 | 18.06 | 0.50 | 2.55 |
| Mar 2023 | 5.58 | 0.87 | 15.59 | 0.36 | 2.40 |
| Mar 2022 | 5.34 | 0.62 | 11.61 | 0.12 | 0.80 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | +4.5% | +16.1% | +2.9% | +27.7% |
| Operating profit growth | +40.3% | +34.5% | -34.2% | -85.7% |
| Net profit growth | +200.0% | +38.9% | -40.0% | -316.7% |
| EPS growth | +200.0% | +6.3% | -72.9% | -208.7% |
| OPM % | 15.6% | 18.1% | 11.5% | 1.3% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Hamps Bio.
Get Free AI Stock Analysis FREE →No recent news available for Hamps Bio.
Hamps Bio shares were last quoted at ₹25.50 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Hamps Bio has a price-to-earnings (P/E) ratio of -30.01 and a price-to-book (P/B) ratio of 2.42. The industry P/E is 53.33.
The 52-week high of Hamps Bio is ₹26.58 and the 52-week low is ₹13.36.
The market capitalisation of Hamps Bio is about ₹19.61 crore.
In the latest quarter (Mar 2026), Hamps Bio reported sales of ₹4.53 crore (+36.0%) and net profit of ₹-0.46 crore (-300.0%), compared with the same quarter last year.
Promoters hold about 71.99% of Hamps Bio.
Hamps Bio belongs to the Trading sector.